Health and Healthcare

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1094 Articles

Chris Lange | Oct 17, 2017 at 9:40 AM EDT

Johnson & Johnson Pharmaceutical, Domestic Sales Fuel Growth

Johnson & Johnson reported better-than-expected fiscal third-quarter financial results before the markets opened on Tuesday.

Chris Lange | Oct 16, 2017 at 11:30 AM EDT

Goldman Sachs and More Dow Earnings Kicking Off Tuesday

Earnings season is just kicking off for the third quarter with markets pushing all-time highs. Seven Dow stocks reporting this…

Chris Lange | Oct 15, 2017 at 10:25 AM EDT

Goldman Sachs, GE, Verizon and More Dow Stocks Reporting This Week

24/7 Wall St. has put together a preview of GE, Verizon and other the Dow Jones Industrial Average companies scheduled…

Paul Ausick | Oct 11, 2017 at 4:01 PM EDT

Walmart, Johnson & Johnson Lift DJIA Wednesday

Walmart, Johnson & Johnson, McDonald's, and Visa pushed the DJIA higher on Wednesday.

Jon C. Ogg | Oct 11, 2017 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Amazon, Facebook, Johnson & Johnson, Schlumberger, Visa, Walmart and More

The top analyst upgrades, downgrades and other research calls from Wednesday include AbbVie, Gilead, Johnson & Johnson, Potash, Schlumberger, Visa…

Lee Jackson | Oct 11, 2017 at 8:25 AM EDT

Deutsche Bank Adds 5 Large Cap Leaders to Conviction List

These five new additions to Deutsche Bank’s Conviction List all make good sense for growth portfolios now.

Jon C. Ogg | Oct 9, 2017 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Ctrip, Goldman Sachs, Johnson & Johnson, Medtronic, Morgan Stanley, Yelp, Yum China and More

The top analyst upgrades, downgrades and other research calls from Monday include Ctrip.com, Goldman Sachs, Johnson & Johnson, Medtronic, Morgan…

Jon C. Ogg | Oct 3, 2017 at 10:55 AM EDT

Credit Suisse Identifies Top Mid-Large Cap Biotech and Pharma Stocks for Big Upside

U.S. pharmaceutical and biotech stocks may have considerable upside if Credit Suisse's views come to pass. But this part of…

Chris Lange | Sep 30, 2017 at 8:20 AM EDT

Major Biotech, Pharma and FDA Catalysts Coming in October

24/7 Wall St. has collected several catalysts that are coming up in October for biotech and pharmaceutical companies.

Jon C. Ogg | Sep 25, 2017 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Albermarle, Blue Apron, Box, Dish Network, GM, Transocean, Under Armour and More

The top analyst upgrades, downgrades and other research calls from Monday include Albermarle, Blue Apron, Box, Dish Network, GM, Transocean…

Paul Ausick | Sep 21, 2017 at 4:01 PM EDT

Apple, Procter & Gamble Sink the DJIA Thursday

Apple, P&G, Johnson & Johnson, and Verizon led the DJIA lower on Thursday.

Jon C. Ogg | Sep 20, 2017 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Biogen, Electronic Arts, Gap, Intuit, J&J, 3M, Intercept, AutoZone and More

The top analyst upgrades, downgrades and other research calls from Wednesday include Biogen, Electronic Arts, Gap, Intuit, Johnson & Johnson,…

Chris Lange | Sep 14, 2017 at 1:35 PM EDT

Why Pfizer Is Pushing the Dow to All-Time Highs

Although the markets were mixed on Thursday, major drug manufacturers proved to be one of the more positive segments on…

Jon C. Ogg | Sep 13, 2017 at 7:15 AM EDT

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

According to Merrill Lynch, the health care sector should act as a good hedge against volatility. Even biotech was shown…

Chris Lange | Sep 11, 2017 at 8:50 AM EDT

Achillion Pharma Slides After Hep C Deal Is Terminated

Achillion Pharmaceuticals saw its shares slump early on Monday after the firm announced that its hepatitis C license and collaboration…

1 … 27 28 29 30 31 … 73

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Johnson & Johnson Pharmaceutical, Domestic Sales Fuel Growth

Goldman Sachs and More Dow Earnings Kicking Off Tuesday

Goldman Sachs, GE, Verizon and More Dow Stocks Reporting This Week

Walmart, Johnson & Johnson Lift DJIA Wednesday

Top Analyst Upgrades and Downgrades: AbbVie, Amazon, Facebook, Johnson & Johnson, Schlumberger, Visa, Walmart and More

Deutsche Bank Adds 5 Large Cap Leaders to Conviction List

Top Analyst Upgrades and Downgrades: Ctrip, Goldman Sachs, Johnson & Johnson, Medtronic, Morgan Stanley, Yelp, Yum China and More

Credit Suisse Identifies Top Mid-Large Cap Biotech and Pharma Stocks for Big Upside

Major Biotech, Pharma and FDA Catalysts Coming in October

Top Analyst Upgrades and Downgrades: Albermarle, Blue Apron, Box, Dish Network, GM, Transocean, Under Armour and More

Apple, Procter & Gamble Sink the DJIA Thursday

Top Analyst Upgrades and Downgrades: Biogen, Electronic Arts, Gap, Intuit, J&J, 3M, Intercept, AutoZone and More

Why Pfizer Is Pushing the Dow to All-Time Highs

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

Achillion Pharma Slides After Hep C Deal Is Terminated

Data Center Expert Warns Gigawatt-Scale AI Buildouts Could Trigger Rolling Blackouts

Jim Cramer on Applied Digital: A $7.5 Billion Contract Isn’t Enough Without Profits

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

At 59, Tapping a $1.5 Million 401(k) First Could Trigger $55,000 in Penalties and Taxes

Data Center Expert Warns Gigawatt-Scale AI Buildouts Could Trigger Rolling Blackouts

Jim Cramer on Applied Digital: A $7.5 Billion Contract Isn’t Enough Without Profits

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Johnson & Johnson Pharmaceutical, Domestic Sales Fuel Growth

Goldman Sachs and More Dow Earnings Kicking Off Tuesday

Goldman Sachs, GE, Verizon and More Dow Stocks Reporting This Week

Walmart, Johnson & Johnson Lift DJIA Wednesday

Top Analyst Upgrades and Downgrades: AbbVie, Amazon, Facebook, Johnson & Johnson, Schlumberger, Visa, Walmart and More

Deutsche Bank Adds 5 Large Cap Leaders to Conviction List

Top Analyst Upgrades and Downgrades: Ctrip, Goldman Sachs, Johnson & Johnson, Medtronic, Morgan Stanley, Yelp, Yum China and More

Credit Suisse Identifies Top Mid-Large Cap Biotech and Pharma Stocks for Big Upside

Major Biotech, Pharma and FDA Catalysts Coming in October

Top Analyst Upgrades and Downgrades: Albermarle, Blue Apron, Box, Dish Network, GM, Transocean, Under Armour and More

Apple, Procter & Gamble Sink the DJIA Thursday

Top Analyst Upgrades and Downgrades: Biogen, Electronic Arts, Gap, Intuit, J&J, 3M, Intercept, AutoZone and More

Why Pfizer Is Pushing the Dow to All-Time Highs

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

Achillion Pharma Slides After Hep C Deal Is Terminated

Data Center Expert Warns Gigawatt-Scale AI Buildouts Could Trigger Rolling Blackouts

Jim Cramer on Applied Digital: A $7.5 Billion Contract Isn’t Enough Without Profits

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

Featured Reads

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

At 59, Tapping a $1.5 Million 401(k) First Could Trigger $55,000 in Penalties and Taxes